Tags (2) : prostate cancer treatment
Accuray and Samsung Explore Volumetric Imaging for CyberKnife
09/28/2026 | Companies
abdominal cancer,
Accuray,
Accuray collaboration,
adaptive radiation therapy,
adaptive radiotherapy,
American Society for Radiation Oncology,
anatomical visualization,
ASTRO 2026,
Boris Geyzer,
cancer care,
cancer imaging,
cancer treatment,
clinical decision-making,
computed tomography,
CT imaging,
CyberKnife,
CyberKnife System,
healthcare technology,
image-guided radiation therapy,
Jonathan Lischalk,
lung cancer treatment,
medical imaging,
medical technology,
mobile computed tomography,
mobile CT,
motion management,
NeuroLogica Corp,
Nicholas van As,
non-coplanar treatment,
oncology,
oncology technology,
pancreatic cancer treatment,
pelvic cancer,
personalized cancer care,
precision oncology,
precision radiation therapy,
precision treatment delivery,
prostate cancer treatment,
radiation oncology,
radiation oncology innovation,
radiation therapy,
radiation therapy innovation,
radiation treatment,
radiosurgery,
radiotherapy,
radiotherapy innovation,
real-time motion management,
robotic radiosurgery,
Samsung Healthcare,
Samsung HME America,
Samsung NeuroLogica,
SBRT,
stereotactic radiosurgery,
Steve La Neve,
The Royal Marsden,
thoracic cancer,
treatment adaptation,
treatment planning,
treatment-room imaging,
volumetric imaging,
volumetric imaging technology
Foresee Pharmaceuticals Reports Positive DSMB Review for Casppian Phase 3 CPP Trial
02/04/2026 | Companies
biopharmaceutical research,
CAMCEVI,
Casppian Phase 3,
central precocious puberty,
clinical trial update,
controlled-release formulation,
CPP,
Data and Safety Monitoring Board,
drug safety,
DSMB safety review,
Foresee Pharmaceuticals,
FP-001,
GnRH therapy,
leuprolide 42 mg,
long-acting injectable,
multinational clinical trial,
pediatric drug development,
pediatric endocrinology,
pharmacokinetics,
Phase 3 study,
prostate cancer treatment,
regulatory milestone
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com


Companies